56:45

Essential

•

The Essential Conversation

Psychedelics: The New Frontier of Mental Health?

Could psychedelic drugs help combat a burgeoning mental health crisis?

46

4

Details Chapters

Featuring Christian Angermayer and Jeff Siegel

Jan 12, 2022 • 56 minutes

With countless people suffering from anxiety and depression in the wake of the COVID-19 pandemic, could psychedelic drugs be poised to become a key treatment? Christian Angermayer, founder of Apeiron Investments, Atai Life Sciences, and COMPASS Pathways, lays out his vision for the future of the psychedelics sector, in which once-taboo substances like psilocybin are administered in clinical settings on a global scale. In a discussion with JLS Fund managing partner Jeff Siegel, the billionaire gives an inside look into some of the recent ups and downs experienced by Atai and COMPASS. He also explains his view on why Atai is currently undervalued and hints at some big things to come. Recorded on January 10, 2022.

The Essential Conversation is the world's premier financial-market-focused conversation series. The smartest people in markets, finance, economics, and business engage in deep-diving discussions about the global macro landscape, generating actionable takeaways that can help your decision-making process. Tune in to peer-to-peer conversations between the brightest minds in the investing world, and tune up your portfolio.

The Essential Conversation is the world's premier financial-market-focused conversation series. The smartest people in markets, finance, economics, and business engage in deep-diving discussions about the global macro landscape, generating actionable takeaways that can help your decision-making process. Tune in to peer-to-peer conversations between the brightest minds in the investing world, and tune up your portfolio.

COMMENTS

Newest First
Oldest First
Top Rated
Most Discussed
Most Controversial

Access Essential Content

This content is reserved for the thousands of visionaries supporting the financial revolution. We'd love for you to join us. Interested?

Already have an account? Log In